ReviewThe role of cytokines in the pathophysiology of suicidal behavior
Introduction
Suicide is a major public health concern. The World Health Organization (WHO) estimated that in the year 2000, approximately one million people died from suicide, and 10–20 times more attempted suicide, worldwide (WHO, 2002). Suicide and suicidal behaviors are cross-diagnostic, multifactorial phenomena. Several clinical, psychosocial and demographic factors have been shown to increase the risk for suicidal behaviors (Hawton et al., 2013). However, predictive value of known risk factors for accurate assessment of who will ultimately make suicide attempts remains low (May et al., 2012). Therefore, identification of relevant biomarkers has assumed increasing importance in suicide research, as objective markers of risk could significantly improve the chances of effective clinical intervention. Moreover, greater understanding of the biological processes impacting neural pathways involved of suicide risk could suggest new treatment approaches.
Even though 90% of suicides have a psychiatric diagnosis (Beautrais et al., 1996), only 5% of psychiatric patients die by suicide. A Stress-Diathesis Model of suicidal behavior was proposed by Mann et al. (1999), in which suicidal behavior was conceptualized as the result of the interplay between stressors such as acute episodes of psychiatric illness or psychosocial stressors, and the individual's constitutional vulnerability to respond with suicidal behavior. This model thus implicates the stress-response system as a potential contributor to the pathophysiology of suicidal behavior. In humans, the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system play key roles in adaptation to physical or psychological stress, acting on numerous systems to maintain homeostasis through the release of corticosteroids and catecholamines (McEwen, 2008). However, chronic stress states in vulnerable individuals can produce alterations of basal and reactive cortisol which, in turn, can have deleterious effects on health. Maladaptive stress responses have been implicated in the pathophysiology of suicidal behavior (Oquendo et al., 2014). As the stress response is intrinsically linked with the immune system, the involvement of inflammatory responses must be considered in suicide-related pathophysiology.
Within the immune system, cytokines such as interleukins (IL), interferons (IFN), and tumor necrosis factor (TNF) play pivotal roles as signaling proteins mediating innate and adaptive immune responses (Commins et al., 2010). T-cell derived cytokines from the Th1 lineage are involved in cellular mediated immune processes (IL-1α, IL-1β, IL-2, IFN-γ, TNF-β) whereas those derived from the Th2 lineage promote humoral immune response (IL-4, IL-6, IL-10) and are implicated in allergic reactions (Chaplin, 2010). Certain cytokines can be functionally categorized as pro-inflammatory (IL-1, IL-6, TNF-α) or anti-inflammatory (IL-4, IL-10, IL-13) (Commins et al., 2010).
The role of cytokines in the pathophysiology of psychiatric disorders was postulated after observations that patients with inflammatory diseases had a higher prevalence of depression, and that symptoms similar to those observed in major depression could be provoked by administration of therapeutic cytokines, such as IFN-α (reviewed in (Raison et al., 2005)). Depression has been associated with increased inflammatory markers, including cytokines such as IL-6 and TNF-α (Liu et al., 2012), although inflammation may be implicated in only a subset of depressed patients (Raison and Miller, 2013).
In recent years, inflammation has emerged as potentially relevant in the pathophysiology of suicidal behavior. The earliest suggestions came from reports of suicidal ideation induced after medical treatment with therapeutic cytokines (Dieperink et al., 2004). A parallel set of discoveries stems from well-replicated findings that the incidence of suicide peaks during the spring, an initially baffling phenomenon later noted to covary with peak season for allergens (Postolache et al., 2008). Additional studies have directly linked allergic conditions to suicide completion (Qin et al., 2011, Timonen et al., 2004). Corroborative evidence is provided from an ecological study showing associations between intranasal corticosteroid anti-inflammatory therapy and lower suicide rates (Woo et al., 2011). In this review, we will focus on the contribution of later studies measuring inflammatory cytokines associated with suicidal behaviors in vivo or, in the case of completed suicide, on postmortem findings. We provide a critical overview of the literature and offer a contextualized interpretation of findings on how cytokine changes may alter brain function to favor suicidal behavior.
Identifying specific inflammatory markers and important contextual factors could inform suicide risk prediction. Treatments targeting constituents of the inflammatory pathway are currently undergoing testing for a variety of psychiatric conditions, and this approach could be developed as a novel therapeutic tool for the prevention of suicide.
Section snippets
Methods
Articles eligible for this review were identified by two investigators (L.G. and S.C.-T.) who independently performed database searches of PubMed from 1980 through February 2015, and Embase, Scopus and PsycINFO from 1980 until 2015 for articles in English (see Fig. 1). The final search strategy comprised the following (with slight differences for individual database logic rules): (suicid* AND (inflammat* OR cytokines OR chemokines OR “receptors, cytokines” OR “tumor necrosis factor” OR
Literature search
We found 22 articles that directly examined relationships between cytokines and suicidal ideation, suicidal behavior or suicide, that fulfilled the inclusion criteria, involving 1813 research participants. Ten articles concerned cytokines in suicide attempts (Huang and Lee, 2007, Isung et al., 2012a, Janelidze et al., 2011, Kim et al., 2008, Li et al., 2013, Lindqvist et al., 2011, Lindqvist et al., 2009, Nässberger and Träskman-Bendz, 1993, Rothenhäusler et al., 2006, Vargas et al., 2013),
Discussion
Taken together, the current literature suggests that inflammation plays a role in suicidal behavior, but the heterogeneity of specific findings, even among the two available meta-analyses, is considerable. Possible explanations for discrepancies among studies include the following: (1) different phenotypes of suicidal behavior may be associated with distinct biological inflammatory patterns, exemplified by findings of Karlović et al. (2012), in which IL-6 levels differed among suicidal compared
Conclusions
Suicide risk has been associated with chronic stress, HPA hyperactivity, serotonergic abnormalities, and in some studies, persistently elevated inflammatory markers, especially elevation of IL-6. Larger, methodologically rigorous studies are needed to draw definitive conclusions regarding the association of inflammatory proteins and suicide. Such studies would contribute to an integrated understanding of the interplay among these different elements, and allow the identification of proximate
Conflicts of interest
Drs. Mann and Oquendo receive royalties from the commercial use of the Columbia Suicide Severity Rating Scale (C-SSRS) from the Research Foundation for Mental Hygiene. Dr. Oquendo’s family owns stock in Bristol Myers Squibb. Drs. Gananca, Sublette, Cisneros-Trujillo and Tyrka have no conflicts to report.
Contributors
Drs. Gananca, Oquendo, Tyrka, Mann and Sublette participated in the conceptualization of the manuscript and interpretation of findings. Dr. Gananca wrote the first draft of the manuscript. Drs. Gananca and Cisneros-Trujillo performed the literature review and selection of articles for inclusion. All authors participated in drafting and/or critically revising the article for important intellectual content and have approved the submitted version.
Funding
Funding sources made no contribution to study design, collection, analysis or interpretation of data, writing of the report, or the decision to submit the article for publication.
Acknowledgements
Sources of Support: MH P50 MH090964 “Conte Center: Neurobiological and Developmental Antecedents to Suicidal Behavior” (Mann and Oquendo); R01 MH101107, R01 MH083704 (Tyrka); American Foundation for Suicide Prevention (Sublette); The Association for Research and Development of the School of Medicine, University of Lisbon (Gananca)
References (123)
- et al.
Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients
Biol. Psychiatry
(2015) - et al.
BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis
Prog. Neurobiol.
(2005) - et al.
Adverse childhood experiences and suicidal behavior
Psychiatry Clin. North Am.
(2008) - et al.
Psychological stress activates interleukin-1beta gene expression in human mononuclear cells
Brain Behav. Immun.
(2005) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Biochim. Biophys. Acta
(2015)- et al.
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions
Neuropsychopharmacology
(2002) - et al.
Anterior cingulate activation and error processing during interferon-alpha treatment
Biol. Psychiatry
(2005) - et al.
Immunologic messenger molecules: cytokines, interferons, and chemokines
J. Allergy Clin. Immunol.
(2010) - et al.
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
Mol. Cell. Endocrinol.
(2011) - et al.
A multiplex immunoassay gives different results than singleplex immunoassays which may bias epidemiologic associations
Clin. Biochem.
(2012)